InVivo Therapeutics Reports University of California San Diego Medical Center as New Site for INSPIRE Study

InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) announced that University of California (UC), San Diego Medical Center has been added as a clinical site for The INSPIRE Study: InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold™ for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury.
According to the company’s press release:

There are now 15 clinical sites participating in the clinical study:

• Banner University Medical Center, Tucson, AZ
• Barnes-Jewish Hospital at Washington University Medical Center, St. Louis, MO
• Barrow Neurological Institute – St. Joseph’s Hospital and Medical Center, Phoenix, AZ
• Carolina Neurosurgery and Spine Associates/Carolinas Rehabilitation, Charlotte, NC
• Cooper Neurological Institute, Camden, NJ
• Goodman Campbell Brain and Spine /Indiana University Health Neuroscience Center, Indianapolis, IN
• Keck Hospital of University of Southern California, Los Angeles, CA
• Medical College of Wisconsin/Froedtert Hospital, Milwaukee, WI
• Mount Sinai Hospital, New York, NY
• Oregon Health & Science University, Portland, OR
• Rutgers New Jersey Medical School, Newark, NJ
• University of California, Davis Medical Center, Sacramento, CA
• University of California, San Diego Medical Center, San Diego, CA
• University of Kansas Medical Center, Kansas City, KS
• University of Pittsburgh Medical Center Presbyterian, Pittsburgh, PA

Mark Perrin, InVivo’s CEO and Chairman, said:

Dr. Ciacci and the team at the UC San Diego Medical Center serve as a valuable addition to our clinical network for The INSPIRE Study.

Click here to view the full press release.